Arthur Peter Bertolino is EVP and Chief Medical Officer at Revance Therapeutics, Inc. (RVNC). They have made 1 open-market trade across 1 company since 2015, most recently 2019-09-01.
CIK 0001426344
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RVNC | SELL | 2015-11-17 | 2015-11-17 | $39.11 | $303K | -26.0% | -1.2% | -49.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.